Announcements Trials
Browse Landscape

Status

Unknown 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 52Observational 3

Sponsor

Cancer Type

Gastrointestinal 9Thoracic 3Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2NSCLC 1

Interventions

Blood Specimen Collection 53Surveys and Questionnaires 30Drug Therapy 27Immunotherapy 25Surgical Procedures, Operative 22Carboplatin 22Nivolumab 21Immune Checkpoint Inhibitors 20pembrolizumab 18osimertinib 18atezolizumab 17Observation 17Radiotherapy 16Bevacizumab 15Cisplatin 14Afatinib 14Specimen Handling 13Gene Expression Profiling 13Erlotinib Hydrochloride 13lorlatinib 12Pemetrexed 12Magnetic Resonance Spectroscopy 11Ipilimumab 11Immunohistochemistry 11Biopsy 11durvalumab 10alectinib 10Paclitaxel 10Bronchoscopy 10Tomography, X-Ray Computed 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × camrelizumab × Thoracic × Clear all
NCT05547737 2022-09-21

NSCLC

Henan Cancer Hospital

Unknown
500 enrolled
Thoracic

NSCLC

NCT04793139 2021-03-11

Efficacy and Safety of Camrelizumab in Real-World Prospective Study

Guangdong Association of Clinical Trials

Unknown
1,000 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04631146 2020-11-17

Efficacy and Safety of Camrelizumab in Real-World Study

Guangdong Association of Clinical Trials

Unknown
450 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡